Fig. 7
Prognostic analysis of HCC patients taking ATO. (A–B) Pre-match RFS and OS analysis. (C–D) Post-matching RFS and OS analysis. group = 0, HCC patients not taking ATO. group = 1, HCC patients taking ATO.
Fig. 7 | Scientific Reports
Prognostic analysis of HCC patients taking ATO. (A–B) Pre-match RFS and OS analysis. (C–D) Post-matching RFS and OS analysis. group = 0, HCC patients not taking ATO. group = 1, HCC patients taking ATO.
